AI Insider’s Post

AI is the future and AI will change everything. When this wonderful video by the The Economist was being made, the drug was in Phase IIa clinical trials. And after the video saw the light, the Phase IIa completed with >98mL increase in FVC after just 12 weeks of dosing and we observed dose-dependent response. Please enjoy this episode by the The Economist and kudos to the team and Adam Jessel 📈🧑🔬🤝🤖 #AI #Science https://lnkd.in/grG7i67D

Here's a simple rule in today's generative AI world: validation is the unavoidable key point on the path to success. After we bridged the intersection of the two major fields in drug discovery through AI, a big challenge arose. Once you scale up and try to utilize AI for drug discovery, you definitely need a different set of expertise. You need a group of drug hunters who can filter and analyze the results produced by AI, and make the final leap. At the center of this group is Dr. Feng Ren. Under his leadership, we have combined the best of artificial intelligence and human intelligence. In this video, we revealed the real-time demo of our biology and chemistry AI platform, which has provided a comprehensive AI-powered end-to-end solution for drug discovery. That allows essentially anyone with the tool to streamline the drug development process, reducing time and cost while increasing the success rate. #GenerativeAI #AIDrugDiscovery #DrugDiscoveryInnovation

In this Forbes article, "High-Demand Human Skills In The Ongoing Age Of AI," Dr. Patrick Smith, President, Drug Development Solutions at Certara and council member of the Forbes Technology Panel, highlights the crucial role of critical thinking and contextualization in leveraging AI effectively. A must-read for anyone interested in the future of AI and human skills! https://ow.ly/qfFH50SrXNS #GenAI #CriticalThinking #RegulatorySubmissions #DrugDevelopment

In 2023, French entrepreneur and scientist, Arthur Mensch, co-founded Mistral AI with the mission of making #GenAI ubiquitous and pioneering a new approach to AI - one that is more open, portable, independent, and accessible to all. In this exclusive interview, Arthur shares his thoughts on Gen AI's sustainability implications and how Mistral AI is bridging the AI talent demand-supply gap. Grab your copy of the Gen AI edition of our #CxO journal "Conversations for Tomorrow" 👉 https://lnkd.in/esCe3PmE #SustainableAI #AItalent

For organisations in the pharma and life sciences (PLS) sector, understanding the stages of GenAI’s adoption is important for the successful implementation of the technology. Our recent study, ‘Generative AI: The next frontier in the transformation of global capability centres for pharma and life sciences’, identifies four levels of organisational maturity – explorers, executors, enablers and empowerers. Learning about these stages can help organisations in leveraging GenAI to improve performance and reduce costs. Read the full report here: https://bit.ly/3yyhNc3 #GenAI #GCC #GCCwithPwC #TogetherWeFuture

In 2023, French entrepreneur and scientist, Arthur Mensch, co-founded Mistral AI with the mission of making #GenAI ubiquitous and pioneering a new approach to AI - one that is more open, portable, independent, and accessible to all. In this exclusive interview, Arthur shares his thoughts on Gen AI's sustainability implications and how Mistral AI is bridging the AI talent demand-supply gap. Grab your copy of the Gen AI edition of our #CxO journal "Conversations for Tomorrow" 👉 https://bit.ly/40hjIx0 #SustainableAI #AItalent

Have you met Hiro, our AI assistant for IP and R&D? We're taking it to the next level by bridging the gap between biopharma and AI. Our newest solution is transforming scientific discovery by helping scientists unlock the potential of their data with generative AI. Tune in on July 18th to learn how Patsnap Hiro is transforming the future of drug R&D. #AI #drugdiscovery #lifesciences #innovation #AskHiro

Great to catch up with Lee Maw, Subroto Mukherjee and Bradley Quinn on how companies in the life sciences industry are driving innovation in with AI. Here’s a few of the key points that we covered; 👩🏽💻Data quality is paramount. Without accurate and reliable data, AI models cannot deliver meaningful or impactful results. ⚖️ Ethics matter. In all industries, particularly life sciences, prioritising patient safety, privacy, and fairness in AI algorithms and decision-making is crucial. 📜 Regulation is evolving. The regulatory landscape will play a critical role in determining how AI can be responsibly and effectively deployed. Life sciences is truly a unique and exciting space for AI, and I’m looking forward to seeing how progress in this area changes the way we live. 🚀 #AI #LifeSciences #DataQuality #AIethics #AIRegulation https://hubs.la/Q02N09jK0

Although #BIO2024 may be over, The Alliance for Artificial Intelligence in Healthcare (AAIH) would like to highlight some amazing panels and discussions that our members were part of! First up, the AI and Regulatory Innovation in Healthcare: Shaping the Future panel featuring Alex Zhavoronkov, Paul Howard, PhD, Mida Pezeshkian, PhD, Christopher Escobedo Hart, Brandon Rice. Throughout their discussion, expert panelists explored the pivotal role of artificial intelligence in regulatory innovation, diving into how AI is reshaping healthcare regulations as well as improving compliance and accelerating approvals. The panelists also uncovered the potential benefits, challenges, and regulatory implications of AI adoption in healthcare. If you missed the panel and want to read more about this topic, you can read the publication here: https://lnkd.in/e6kza8P3 #AAIH #AI #aiinhealthcare #innovation #AIinnovation #Regulatoryinnovation

#AI’s potential to transform scientific research is boundless. Over the next decade, HHMI will embed AI throughout the scientific process to catalyze an explosion of knowledge about the living world. Learn more about our exciting $500 million initiative to accelerate scientific discovery through AI-driven research at https://lnkd.in/exm-VbzN. #MovingScienceForward